Han Yong Choi
Overview
Explore the profile of Han Yong Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
1944
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoo G, Park W, Pyo H, Jeong B, Jeon H, Kang M, et al.
Cancer Res Treat
. 2021 Apr;
54(1):218-225.
PMID: 33857365
Purpose: We aimed to investigate the risk factors and patterns of locoregional recurrence (LRR) after radical nephrectomy (RN) in patients with locally advanced renal cell carcinoma (RCC). Materials And Methods:...
2.
Lee H, Sa J, Gualberto A, Scholz C, Sung H, Jeong B, et al.
Clin Cancer Res
. 2020 Jul;
26(19):5113-5119.
PMID: 32636318
Purpose: To assess the antitumor activity and safety of tipifarnib, a highly potent and selective farnesyltransferase inhibitor, we performed a phase II clinical trial in patients with advanced and refractory...
3.
Kang M, Yoo H, Kim K, Sung S, Jeon H, Park S, et al.
J Cancer
. 2019 Dec;
10(27):6896-6902.
PMID: 31839824
: To determine whether adjuvant chemotherapy (ACH) influences cancer-specific mortality, bladder cancer-specific mortality, and other-cause mortality in patients with locally advanced upper tract urothelial carcinoma (UTUC) following radical nephroureterectomy (RNU)...
4.
Shin S, Kim T, Sung H, Jeon H, Jeong B, Park S, et al.
Clin Genitourin Cancer
. 2019 Sep;
17(6):e1137-e1146.
PMID: 31473122
Background: We aimed to develop a modified International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model that can predict early death less than 1 year in patients with metastatic renal...
5.
Kang M, Cho E, Jang J, Lee J, Jeon Y, Jeong B, et al.
Investig Clin Urol
. 2019 Jul;
60(4):227-234.
PMID: 31294131
Purpose: To analyze the characteristics of somatic mutations and copy number alterations (CNAs) in Korean patients with advanced prostate cancer (PCa) by use of the Oncomine Comprehensive Panel (ThermoFisher Scientific)...
6.
Yoon S, Kim Y, Cho J, Kang M, Sung H, Jeon H, et al.
BMC Urol
. 2019 May;
19(1):30.
PMID: 31053137
Background: Results from randomized phase III trials have shown that thrice-weekly docetaxel added to androgen-deprivation therapy (ADT) has a significant impact on the survival of patients with metastatic castration-naïve prostate...
7.
Song W, Jeong J, Jeon H, Seo S, Jeon S, Choi H, et al.
Int J Surg
. 2019 Apr;
66:12-17.
PMID: 31018160
Objective: We investigated the impact of cisplatin-based adjuvant chemotherapy (AC) on oncologic outcomes including recurrence-free survival (RFS), cancer-specific survival (CSS) and overall survival (OS) after radical nephroureterectomy (RNU) for patients...
8.
Kim T, Suh Y, Jeon H, Jeong B, Seo S, Jeon S, et al.
Sci Rep
. 2019 Apr;
9(1):6294.
PMID: 31000756
This study aimed to compare the oncologic outcomes between retroperitoneal radical nephroureterectomy (rRNU) and transperitoneal radical nephroureterectomy (tRNU) for the treatment of patients with upper urinary tract urothelial carcinoma (UTUC)....
9.
Kim J, Suh Y, Kim T, Jeon S, Lee H, Choi H, et al.
Sci Rep
. 2019 Jan;
9(1):770.
PMID: 30683879
Extra-transitional zone density (ETzD), a novel parameter is proposed to stratify the deviation of prostate specific antigen (PSA) due to structural change according to stromal hyperplasia of prostate. ETzD was...
10.
Choi Y, Han D, Kim S, Kim M, Sung H, Jeon H, et al.
Prostate
. 2019 Jan;
79(6):614-621.
PMID: 30671976
Background: The anti-cancer activities of curcumin are well-documented from preclinical studies using prostate cancer models. Our objective was to evaluate the anti-cancer activity of oral curcumin in patients with prostate...